NCT05283122

Brief Summary

Post - partum haemorrhage is still a headache to all obstetricians around the whole world . Every obstetrician exerts his own full effort to control bleeding which can occur post-partum by applying all maneuvers to preserve the fertility and the uterus for the patient . demonstration of ( Mostafa Maged ) technique is applied to control and prevent post-partum haemorrhage . It is so simple maneuver and easy to be applied within short period of time .Satisfactory hemostasis can be assessed after application .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 16, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

March 24, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2022

Completed
Last Updated

August 1, 2022

Status Verified

July 1, 2022

Enrollment Period

2 months

First QC Date

March 8, 2022

Last Update Submit

July 27, 2022

Conditions

Keywords

Mostafa Maged techniqueplacenta previalower uterine segmentcaeserian section

Outcome Measures

Primary Outcomes (1)

  • primary post-partum bleeding

    prevention and management of bleeding from lower segment ....estimation of number of pads used during section to estimate blood loss ... and to assess the number of blood loss postpartum roughly visually

    twenty-four hours post-partum

Study Arms (1)

The Mostafa Maged technique to prevent and control post-partum bleeding in placenta previa cases

EXPERIMENTAL

primigravida patients with placenta previa conditions and their ages between ( 18 - 30 ) years old

Procedure: Mostafa Maged Technique

Interventions

pfannestiel incision . dissection of the bladder downwards , and Ligation of the uterine arteries on both sides then , we turn over the upper part of the lower uterine segment onto the lower part of the lower uterine segment from the inside of uterine cavity .We do this turnover (flipping ) by our hands and holding the imaginary line by two Allis forceps and by making three knots by three needles in the lower edge of the uterine incision and we enter the needles of simultaneously into the lower segment through the uterine cavity , at the same level of , the inside wall of lower uterine segment to drag the upper (half) part of the lower uterine segment on the lower part of lower uterine segment ( sandwich - like ) Third , we stitch the both sides of the flipped lower uterine segment , then we do plication of the anterior lower uterine segments to strengthen the wall of the flipped lower uterine segment and place a drain in the doglus pouch

The Mostafa Maged technique to prevent and control post-partum bleeding in placenta previa cases

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • pregnant primigravida patients with placenta previa
  • to 30 years old

You may not qualify if:

  • patients with bleeding disorders
  • smokers
  • morbid obese patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fayoum general hospital and Fayoum university

Al Fayyum, 0020, Egypt

Location

MeSH Terms

Conditions

Placenta Previa

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: primigravida pregnant patients with placenta previa conditions
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 8, 2022

First Posted

March 16, 2022

Study Start

March 24, 2022

Primary Completion

May 20, 2022

Study Completion

May 20, 2022

Last Updated

August 1, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations